Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $27 | $20 | $19 | $17 |
| Short-Term Investments | $0 | $97 | $114 | $132 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $81 | $6 | $5 | $4 |
| Total Curr. Assets | $108 | $123 | $137 | $153 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $110 | $125 | $140 | $156 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $4 | $5 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $8 | $6 | $5 |
| Total Curr. Liab. | $17 | $13 | $12 | $12 |
| LT Debt | $0 | $1 | $1 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $2 | $3 | $3 |
| Total Liabilities | $17 | $14 | $13 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$535 | -$512 | -$494 | -$477 |
| AOCI | -$0 | -$0 | -$0 | $0 |
| Other Equity | $627 | $623 | $621 | $619 |
| Total Equity | $92 | $111 | $127 | $142 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $110 | $125 | $140 | $156 |
| Net Debt | -$25 | -$18 | -$16 | -$14 |